[Effect of Topiramate on Drug Associated Weight Gain of Patients with Schizophrenia and Bipolar I Disorders: A Dose Ranging Randomized Trial].

CONCLUSION: All doses of 50, 100, and 200mg were shown effective in preventing olanzapine-related obesity in schizophrenic and/or bipolar patients.
PMID: 27370059 [PubMed - in process]

Source: Turkish Journal of Psychiatry - July 4, 2016 Category: Psychiatry Authors: Talaeı A, Farıdhosseını F, Kazemı H, Fayyazı Bordbar MR, Rezaeı Ardanı A Tags: Turk Psikiyatri Derg Source Type: research